Shanghai RAAS Blood Products Co Ltd
SZSE:002252

Watchlist Manager
Shanghai RAAS Blood Products Co Ltd Logo
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Watchlist
Price: 7.22 CNY -0.41% Market Closed
Market Cap: 47.9B CNY
Have any thoughts about
Shanghai RAAS Blood Products Co Ltd?
Write Note

Income Statement

Earnings Waterfall
Shanghai RAAS Blood Products Co Ltd

Revenue
8.3B CNY
Cost of Revenue
-5.1B CNY
Gross Profit
3.3B CNY
Operating Expenses
-979.1m CNY
Operating Income
2.3B CNY
Other Expenses
-467.5m CNY
Net Income
1.8B CNY

Income Statement
Shanghai RAAS Blood Products Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
860
N/A
1 320
+54%
1 422
+8%
1 594
+12%
1 986
+25%
2 013
+1%
2 144
+6%
2 235
+4%
2 138
-4%
2 326
+9%
2 241
-4%
2 155
-4%
2 177
+1%
1 928
-11%
1 844
-4%
2 021
+10%
1 869
-8%
1 804
-3%
2 072
+15%
2 141
+3%
2 311
+8%
2 585
+12%
2 732
+6%
2 597
-5%
2 707
+4%
2 762
+2%
2 884
+4%
3 208
+11%
3 770
+18%
4 288
+14%
5 119
+19%
5 826
+14%
6 193
+6%
6 567
+6%
6 945
+6%
7 174
+3%
7 551
+5%
7 964
+5%
7 957
0%
8 316
+5%
8 343
+0%
Gross Profit
Cost of Revenue
(327)
(494)
(534)
(593)
(753)
(777)
(780)
(832)
(795)
(845)
(861)
(829)
(821)
(706)
(676)
(708)
(655)
(617)
(717)
(765)
(824)
(936)
(996)
(928)
(1 022)
(1 060)
(1 175)
(1 374)
(1 725)
(2 069)
(2 649)
(3 165)
(3 403)
(3 678)
(3 947)
(4 122)
(4 437)
(4 735)
(4 837)
(5 037)
(5 067)
Gross Profit
533
N/A
825
+55%
888
+8%
1 001
+13%
1 233
+23%
1 236
+0%
1 364
+10%
1 403
+3%
1 344
-4%
1 482
+10%
1 380
-7%
1 326
-4%
1 356
+2%
1 222
-10%
1 168
-4%
1 313
+12%
1 214
-8%
1 187
-2%
1 354
+14%
1 376
+2%
1 487
+8%
1 649
+11%
1 737
+5%
1 669
-4%
1 685
+1%
1 702
+1%
1 710
+0%
1 835
+7%
2 045
+11%
2 219
+8%
2 470
+11%
2 660
+8%
2 789
+5%
2 889
+4%
2 998
+4%
3 052
+2%
3 114
+2%
3 229
+4%
3 120
-3%
3 279
+5%
3 276
0%
Operating Income
Operating Expenses
(175)
(242)
(259)
(290)
(330)
(395)
(384)
(385)
(386)
(380)
(359)
(404)
(434)
(325)
(453)
(447)
(497)
(720)
(956)
(1 029)
(1 036)
(785)
(890)
(823)
(802)
(643)
(783)
(803)
(854)
(730)
(1 134)
(1 195)
(1 225)
(886)
(1 076)
(1 091)
(1 091)
(897)
(845)
(954)
(979)
Selling, General & Administrative
(175)
(180)
(259)
(285)
(322)
(267)
(370)
(372)
(365)
(274)
(353)
(372)
(373)
(316)
(382)
(415)
(493)
(603)
(632)
(683)
(682)
(651)
(666)
(605)
(582)
(495)
(555)
(575)
(611)
(579)
(647)
(694)
(716)
(713)
(725)
(723)
(716)
(713)
(702)
(781)
(771)
Research & Development
0
(46)
0
0
0
(101)
0
0
0
(77)
0
0
(26)
(97)
0
0
(47)
(92)
(78)
(102)
(107)
(97)
(99)
(99)
(104)
(125)
(130)
(129)
(138)
(122)
(142)
(149)
(153)
(140)
(157)
(168)
(176)
(169)
(178)
(193)
(232)
Depreciation & Amortization
0
(18)
0
0
0
(27)
0
0
0
(30)
0
0
0
53
0
0
0
(57)
0
0
0
(62)
0
0
0
(63)
0
0
0
(57)
0
0
0
(48)
0
0
0
(37)
0
0
0
Other Operating Expenses
(0)
2
1
(5)
(9)
(0)
(15)
(14)
(21)
(0)
(7)
(32)
(35)
35
(71)
(33)
43
32
(246)
(244)
(248)
26
(125)
(119)
(116)
40
(98)
(100)
(105)
28
(345)
(353)
(355)
16
(194)
(199)
(199)
22
34
20
24
Operating Income
358
N/A
583
+63%
630
+8%
711
+13%
903
+27%
841
-7%
980
+17%
1 018
+4%
957
-6%
1 102
+15%
1 020
-7%
922
-10%
922
+0%
898
-3%
714
-20%
866
+21%
717
-17%
467
-35%
399
-15%
346
-13%
451
+30%
864
+92%
847
-2%
847
+0%
883
+4%
1 059
+20%
927
-13%
1 031
+11%
1 191
+15%
1 489
+25%
1 335
-10%
1 465
+10%
1 565
+7%
2 004
+28%
1 921
-4%
1 961
+2%
2 022
+3%
2 332
+15%
2 274
-2%
2 325
+2%
2 297
-1%
Pre-Tax Income
Interest Income Expense
11
16
345
680
718
888
666
504
870
846
806
1 061
638
110
(759)
(1 672)
(2 337)
(2 032)
(1 085)
(621)
36
11
1
211
391
571
676
684
642
434
388
328
302
472
554
511
471
(102)
26
(8)
75
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(187)
(0)
0
1
(140)
4
6
5
(132)
0
(2)
(2)
(372)
(1)
(0)
(0)
(199)
0
0
0
(7)
(1)
(1)
(2)
Gain/Loss on Disposition of Assets
0
(1)
(1)
0
(1)
(0)
(0)
(0)
(1)
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
0
4
5
8
18
20
29
22
12
11
18
19
18
(3)
(20)
(18)
(17)
(4)
(5)
(5)
(5)
(2)
(13)
(26)
(26)
(22)
(15)
(2)
(15)
(13)
(14)
(14)
(2)
(3)
(6)
(8)
(12)
(18)
(33)
(97)
(111)
Pre-Tax Income
369
N/A
602
+63%
978
+63%
1 399
+43%
1 638
+17%
1 749
+7%
1 675
-4%
1 543
-8%
1 838
+19%
1 959
+7%
1 844
-6%
2 002
+9%
1 579
-21%
1 005
-36%
(65)
N/A
(823)
-1 165%
(1 637)
-99%
(1 756)
-7%
(691)
+61%
(279)
+60%
483
N/A
733
+52%
839
+14%
1 038
+24%
1 254
+21%
1 477
+18%
1 588
+7%
1 711
+8%
1 815
+6%
1 539
-15%
1 709
+11%
1 778
+4%
1 864
+5%
2 274
+22%
2 469
+9%
2 465
0%
2 482
+1%
2 204
-11%
2 266
+3%
2 219
-2%
2 260
+2%
Net Income
Tax Provision
(56)
(92)
(149)
(212)
(249)
(269)
(257)
(242)
(288)
(309)
(295)
(315)
(255)
(173)
(15)
98
235
233
77
18
(106)
(127)
(142)
(150)
(160)
(159)
(153)
(178)
(197)
(250)
(298)
(340)
(368)
(401)
(424)
(412)
(423)
(427)
(450)
(438)
(430)
Income from Continuing Operations
313
511
829
1 187
1 389
1 480
1 418
1 302
1 550
1 650
1 549
1 687
1 323
832
(80)
(726)
(1 402)
(1 523)
(614)
(261)
377
606
697
888
1 094
1 319
1 434
1 533
1 619
1 289
1 410
1 438
1 496
1 873
2 045
2 053
2 059
1 777
1 816
1 781
1 830
Income to Minority Interest
1
0
(6)
(18)
(30)
(38)
(42)
(42)
(42)
(37)
(26)
(14)
(4)
4
4
6
5
5
4
3
4
2
3
4
4
5
5
4
5
6
6
7
6
7
5
5
5
2
1
1
(1)
Net Income (Common)
315
N/A
511
+62%
823
+61%
1 169
+42%
1 359
+16%
1 442
+6%
1 376
-5%
1 259
-8%
1 508
+20%
1 613
+7%
1 523
-6%
1 673
+10%
1 320
-21%
836
-37%
(76)
N/A
(720)
-851%
(1 397)
-94%
(1 518)
-9%
(610)
+60%
(258)
+58%
380
N/A
608
+60%
700
+15%
892
+27%
1 098
+23%
1 324
+21%
1 439
+9%
1 537
+7%
1 624
+6%
1 295
-20%
1 416
+9%
1 445
+2%
1 502
+4%
1 880
+25%
2 051
+9%
2 058
+0%
2 064
+0%
1 779
-14%
1 818
+2%
1 781
-2%
1 830
+3%
EPS (Diluted)
0.07
N/A
0.1
+43%
0.17
+70%
0.24
+41%
0.28
+17%
0.29
+4%
0.28
-3%
0.26
-7%
0.31
+19%
0.32
+3%
0.31
-3%
0.34
+10%
0.27
-21%
0.17
-37%
-0.01
N/A
-0.14
-1 300%
-0.28
-100%
-0.31
-11%
-0.13
+58%
-0.06
+54%
0.07
N/A
0.12
+71%
0.14
+17%
0.13
-7%
0.18
+38%
0.21
+17%
0.22
+5%
0.23
+5%
0.24
+4%
0.19
-21%
0.21
+11%
0.21
N/A
0.22
+5%
0.28
+27%
0.3
+7%
0.31
+3%
0.31
N/A
0.27
-13%
0.27
N/A
0.27
N/A
0.28
+4%

See Also

Discover More